BMS’s Opdivo and Yervoy colorectal cancer trials show promising results
BMS presented this data supporting the use of immune checkpoint inhibitors (ICIs) in combination in patients with newly diagnosed advanced colorectal cancer subtypes at the ASCO Gastrointestinal Cancer Symposium. Credit: Tada Images / Shutterstock. On January 22, BMS announced encouraging findings from the CheckMate -8HW clinical trial, showing that the combination of Opdivo (nivolumab) and […]
Research identifies promising treatment for advanced colorectal cancer
An international phase 3 clinical trial showed that patients with metastatic colorectal cancer who carry a rare genetic tumor mutation called KRAS G12C received a combination of the KRAS inhibitor sotorasib and the monoclonal antibody panitumumab compared to standard treatment. It was found that an excellent progression-free survival rate was achieved. City of Hope is […]
Promising results from new colorectal cancer treatment
Credit: Peter McCallum Cancer Center A new pill treatment called Divarasib has been shown to be highly effective in treating a difficult type of intestinal (colorectal) cancer associated with the KRAS G12C mutation. research result, natural medicine Today (December 5), researchers showed remarkable results that when divarasib was given in combination with another cancer drug […]